传奇生物11款早期细胞疗法管线正在推进;礼来GLP-1药物销售不及预期|医药早参

每日经济新闻
16 Jan

每经记者:陈星每经编辑:董兴生| 2025年1月16日 星期四 |NO.1 传奇生物11款早期细胞疗法管线正在推进北京时间1月15日,传奇生物首席执行官黄颖博士在第43届摩根大通医疗健康年会(JPM)发表演讲。黄颖介绍了传奇生物核心产品进展、核心技术平台和在研管线。该公司目前已构建起包含11条早期研发管线的CAR-T细胞治疗产品组合,涵盖血液系统恶性肿瘤、实体瘤、自身免疫疾病等多个领域。点评:报告...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10